Almoosa Health Company (TADAWUL:4018)

Saudi Arabia · Delayed Price · Currency is SAR

135.90

+3.00 (2.26%)

Mar 24, 2026, 12:25 PM AST

Revenue by Segment

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Medical Services	917.50M	825.55M	735.45M	661.45M	577.23M
Medical Services Growth	11.14%	12.25%	11.19%	14.59%	11.08%
Rehabilitation	180.90M	118.54M	56.82M	-	-
Rehabilitation Growth	52.60%	108.64%	-	-	-
Pharmaceuticals	317.90M	258.24M	186.71M	154.59M	124.31M
Pharmaceuticals Growth	23.10%	38.31%	20.78%	24.36%	13.71%
Total	1.42B	1.20B	978.97M	816.04M	701.54M
Total Growth	17.80%	22.82%	19.97%	16.32%	11.54%

Revenue by Geography

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Saudi Arabia	1.42B	1.20B	978.97M	816.04M	701.54M
Saudi Arabia Growth	17.80%	22.82%	19.97%	16.32%	11.54%
Total	1.42B	1.20B	978.97M	816.04M	701.54M
Total Growth	17.80%	22.82%	19.97%	16.32%	11.54%

Source: S&P Global Market Intelligence.